Caricamento...
Decreased serum level of sphingosine‐1‐phosphate: a novel predictor of clinical severity in COVID‐19
The severity of coronavirus disease 2019 (COVID‐19) is a crucial problem in patient treatment and outcome. The aim of this study is to evaluate circulating level of sphingosine‐1‐phosphate (S1P) along with severity markers, in COVID‐19 patients. One hundred eleven COVID‐19 patients and forty‐seven h...
Salvato in:
| Pubblicato in: | EMBO Mol Med |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7744841/ https://ncbi.nlm.nih.gov/pubmed/33190411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202013424 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|